Bio Invest Advisor

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $22.71 Feb 15, 2025

Gossamer Bio Receives Reaffirmed Buy Rating from HC Wainwright Jan 31, 2025

JPMorgan Chase & Co. Significantly Increases Stake in Nuvation Bio Inc. Jan 26, 2025

Cabaletta Bio, Inc. Experiences Significant Drop in Short Interest Oct 29, 2024